ARCHIVES

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

NCI Funding Plan For 1983: 20% Cut From Recommended Levels for All Grants, Change In Program Projects

October 8, 1982

Breast Cancer Working Group Lists Research Needed

July 1, 1988

NCI-Approved Clinical Trials

December 30, 2005

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

December 1, 2006